118 related articles for article (PubMed ID: 6783152)
1. Effects of bromhexine metabolite VIII (NA 872) in an animal model of the respiratory distress syndrome.
Dauberschmidt R; Kuckelt W; Bender V; Hieronymi U; Mrochen H; Winsel K; Zinsmeyer J; Meyer M
Bull Eur Physiopathol Respir; 1980; 16(2):135-43. PubMed ID: 6783152
[No Abstract] [Full Text] [Related]
2. [Prevention and therapy of respiratory distress syndrome in premature infants by means of bromhexine metabolite VIII. Animal experimental studies on the therapeutic efficacy of bromhexine metabolite VIII in premature respiratory distress syndrome].
Endell W; Grosspietzsch R; Klink F; von Klitzing L; Oberheuser F
Fortschr Med; 1977 Sep; 95(25):2145-8. PubMed ID: 242957
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of ambroxol--review and new results.
Disse BG
Eur J Respir Dis Suppl; 1987; 153():255-62. PubMed ID: 3322865
[TBL] [Abstract][Full Text] [Related]
4. Application of bromhexine metabolite VIII (NA 872) and bromhexine-glucose in treatment of adult respiratory distress syndrome; experimental and clinical results .
Kuckelt W; Dauberschmidt R; Scharfenberg J; Winsel K; Lachmann B; Frenzke H; Hieronymi U; Mrochen H; Meyer M
Respiration; 1980; 39(5):264-71. PubMed ID: 7414106
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
Wiessmann KJ; Niemeyer K
Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
[TBL] [Abstract][Full Text] [Related]
6. [Inhalation therapy with the new antisecretory drug ambroxol (metabolite VIII of bromhexine) in otorhinolaryngology].
Hoffmann H
Arzneimittelforschung; 1978; 28(5a):931-3. PubMed ID: 581993
[No Abstract] [Full Text] [Related]
7. [Effect of Lasolvan on the course of respiratory distress syndrome in newborn infants].
Bajorek J; Czeszyńska M; Gizejowska M; Baryła-Pankiewicz E
Pediatr Pol; 1987 Jun; 62(6):382-7. PubMed ID: 3670928
[No Abstract] [Full Text] [Related]
8. [Physiopathology and biochemistry in the acute respiratory distress syndrome--animal experiment studies].
Dauberschmidt R; Bender V; Kuckelt W; Winsel K; Zinsmeyer J; Hieronymi H; Mrochen H; Meyer M
Z Med Lab Diagn; 1982 Apr; 23(2):104-9. PubMed ID: 6810566
[No Abstract] [Full Text] [Related]
9. [Use of ambroxol in the therapy of neonatal respiratory insufficiency].
Colombo ML; Dogliani P; Ulla L
Minerva Pediatr; 1988 Jun; 40(6):333-8. PubMed ID: 3185433
[No Abstract] [Full Text] [Related]
10. [RDS prevention by prednilyden and ambroxol. A comparative study].
Geibel W; Rindt W; Becker H
Arch Gynecol; 1979 Jul; 228(1-4):204. PubMed ID: 582652
[No Abstract] [Full Text] [Related]
11. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
[TBL] [Abstract][Full Text] [Related]
12. Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function.
Ericsson CH; Juhász J; Jönsson E; Mossberg B
Eur J Respir Dis; 1986 Oct; 69(4):248-55. PubMed ID: 3545883
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with ambroxol syrup (author's transl)].
Göbel P; Rensch H
Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
[TBL] [Abstract][Full Text] [Related]
14. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the effects of ambroxol in the surgical preparation of patients with bronchopulmonary disorders. Administration during intermittent positive pressure ventilation].
Minuto A; Corino T; Ceccopieri M; Bardi F
Clin Ter; 1984 Dec; 111(6):521-30. PubMed ID: 6396029
[No Abstract] [Full Text] [Related]
16. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
Primbs K
Clin Ther; 1985; 7(6):733-6. PubMed ID: 4075364
[TBL] [Abstract][Full Text] [Related]
17. [Functional examination of the lungs in evaluating the effect of respiratory rehabilitation and mucolytics in cystic fibrosis].
Zapletal A; Vávrová V; Stefanová J; Horák J; Samánek M
Cesk Pediatr; 1983 Sep; 38(9):519-24. PubMed ID: 6640752
[No Abstract] [Full Text] [Related]
18. Effect of bromhexine, ambroxol, and placebo on clinical and histopathological changes in "Sjögren" mice.
Prause JU; Jensen OA; Manthorpe R
Graefes Arch Clin Exp Ophthalmol; 1985; 223(5):259-64. PubMed ID: 4065592
[TBL] [Abstract][Full Text] [Related]
19. Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo.
Marini A; Franzetti M; Gios G; Flauto U; Arosio A; Maccabruni M; Rondini G; Chirico G; Giancola A; Console V
Respiration; 1987; 51 Suppl 1():60-7. PubMed ID: 3299568
[TBL] [Abstract][Full Text] [Related]
20. [Tissue-plasminogen-activators of maternal and fetal rat lungs after application of betamethasone or bromhexine-metabolite VIII (author's transl)].
Haas-Denk S; Krieglsteiner P; Wriedt-Lübbe I; Erhardt W; Münnich W; Blümel G
Z Geburtshilfe Perinatol; 1976 Dec; 180(6):398-403. PubMed ID: 1014776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
